These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9701729)

  • 1. Autocrine motility factor in pulmonary adenocarcinomas: results of an immunohistochemical study.
    Takanami I; Takeuchi K; Naruke M; Kodaira S; Tanaka F; Watanabe H; Raz A
    Tumour Biol; 1998; 19(5):384-9. PubMed ID: 9701729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
    Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K; Raz A
    Int J Cancer; 2001 Nov; 95(6):384-7. PubMed ID: 11668522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
    Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A
    Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine motility factor receptor expression as a prognostic factor in pulmonary adenocarcinoma.
    Takanami I; Kodaira S; Tanaka F; Watanabe H; Raz A
    Oncol Rep; 1997; 4(5):949-51. PubMed ID: 21590173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
    Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
    Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
    Silletti S; Paku S; Raz A
    Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
    Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
    Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine motility factor-receptor gene expression in lung cancer.
    Takanami I; Takeuchi K
    Jpn J Thorac Cardiovasc Surg; 2003 Aug; 51(8):368-73. PubMed ID: 12962414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
    Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
    Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma.
    Takanami I; Takeuchi K; Naruke M
    Oncol Rep; 2000; 7(5):1065-7. PubMed ID: 10948339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid.
    Funasaka T; Haga A; Raz A; Nagase H
    Biochem Biophys Res Commun; 2002 Apr; 293(1):192-200. PubMed ID: 12054583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
    Hirono Y; Fushida S; Yonemura Y; Yamamoto H; Watanabe H; Raz A
    Br J Cancer; 1996 Dec; 74(12):2003-7. PubMed ID: 8980404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
    Funasaka T; Haga A; Raz A; Nagase H
    Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
    Jiang WG; Raz A; Douglas-Jones A; Mansel RE
    J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
    Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
    Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of autocrine motility factor in tumor and tumor microenvironment.
    Funasaka T; Raz A
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):725-35. PubMed ID: 17828376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study].
    Zhang J; Liang ZY; Luo YF; Wan JW; Cao JL; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):651-6. PubMed ID: 20078967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Significance of S100A10 Expression in Lung Adenocarcinomas.
    Katono K; Sato Y; Jiang SX; Kobayashi M; Saito K; Nagashio R; Ryuge S; Satoh Y; Saegusa M; Masuda N
    Asian Pac J Cancer Prev; 2016; 17(1):289-94. PubMed ID: 26838226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
    Kamimura A; Kamachi M; Nishihira J; Ogura S; Isobe H; Dosaka-Akita H; Ogata A; Shindoh M; Ohbuchi T; Kawakami Y
    Cancer; 2000 Jul; 89(2):334-41. PubMed ID: 10918163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.